Portella, MJ, Arteaga-Henríquez, G, de Diego-Adeliño, J, Trujols, J, Puigdemont, D, Pérez, J, Alemany, C, Carrasco-Hernández, J, Udina, M, Cardoner, N, Vicent-Gil, M. Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?. GENERAL HOSPITAL PSYCHIATRY. 2025; 92DOI:10.1016/j.genhosppsych.2024.10.003. PMID:39395857. IF:3.700(Q1/3D).

Seppälä, J, Grasa, E, Alonso-Solis, A, Roldan-Bejarano, A, Haapea, M, Isohanni, M, Miettunen, J, Mendivelso, JC, Almazán, C, Rubinstein, K, Caspi, A, Unoka, Z, Farkas, K, Reixach, E, Berdun, J, Usall, J, Ochoa, S, Corripio, I, Jääskeläinen, E. Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study. Jmir Human Factors. 2025; 12DOI:10.2196/67659. PMID:40372941. IF:(Q/D).

Casanovas, F, Dinamarca, F, Posso, M, Mané, A, Oller, S, Córcoles, D, Macià, F, Sala, M, Pérez-Sola, V, Ruiz, AI. Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis. PSYCHIATRY RESEARCH. 2024; 342DOI:10.1016/j.psychres.2024.116206. PMID:39321636. IF:3.900(Q1/2D).

Núñez, C, Stephan-Otto, C, Roldán, A, Grasa, EM, Escartí, MJ, García-Iturrospe, EJA, García-Martí, G, de la Iglesia-vaya, M, Nacher, J, Portella, MJ, Corripio, I. Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 89DOI:10.1016/j.euroneuro.2024.09.006. PMID:39341083. IF:6.700(Q1/1D).

Kiebs, M, Farrar, DC, Yrondi, A, Cardoner, N, Tuovinen, N, Redlich, R, Dannlowski, U, Soriano-Mas, C, Dols, A, Takamiya, A, Tendolkar, I, Narr, KL, Espinoza, R, Laroy, M, van Eijndhoven, P, Verwijk, E, van Waarde, J, Verdijk, J, Maier, HB, Nordanskog, P, van Wingen, G, van Diermen, L, Emsell, L, Bouckaert, F, Repple, J, Camprodon, JA, Wade, BSC, Donaldson, KT, Oltedal, L, Kessler, U, Hammar, A, Sienaert, P, Hebbrecht, K, Urretavizcaya, M, Belge, JB, Argyelan, M, Baradits, M, Obbels, J, Draganski, B, Philipsen, A, Sartorius, A, Rhebergen, D, Ousdal, OT, Hurlemann, R, McClintock, S, Erhardt, EB, Abbott, CC. Electroconvulsive therapy and cognitive performance from the Global ECT MRI Research Collaboration. JOURNAL OF PSYCHIATRIC RESEARCH. 2024; 179DOI:10.1016/j.jpsychires.2024.09.013. PMID:39312853. IF:3.200(Q2/4D).

Jordà-Baleri, T, Garriga, M, Mezquida, G, Cuesta, MJ, Martinez-Aran, A, Garcia-Rizo, C, Lobo, A, González-Pinto, A, Diaz-Caneja, CM, Roldán, A, Vieta, E, Baeza, I, Trabsa, A, Montalvo, I, Tortorella, A, Menculini, G, Verdolini, N, Ramos-Quiroga, JA, Torres, AMS, Bernardo, M, Amoretti, S. Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episode. PSYCHONEUROENDOCRINOLOGY. 2024; 169DOI:10.1016/j.psyneuen.2024.107112. PMID:39106582. IF:3.600(Q1/3D).